A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
36 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Birmingham Psychiatry Pharmaceutical Studies, Inc.
Birmingham, Alabama, United States
- K&s Professional Research Services
Little Rock, Arkansas, United States
- Affiliated Research Institute
San Diego, California, United States
- Yale University
New Haven, Connecticut, United States
- Behavioral Clinical Research
North Miami, Florida, United States
- Clinical Neuroscience Solution, Inc.
Orlando, Florida, United States
- University of South Florida College of Medicine
Tampa, Florida, United States
- Atlanta Center for Medical Research
Atlanta, Georgia, United States
- Carman Research
Smyrna, Georgia, United States
- Valle Vista Health System
Greenwood, Indiana, United States
- Louisiana State University Health Sciences Center
Shreveport, Louisiana, United States
- Johns Hopkins School of Medicine
Baltimore, Maryland, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Mayo Clinic Department of Pscyhiatry & Psychology
Rochester, Minnesota, United States
- Behavioral Medical Research of States Island
Staten Island, New York, United States
- Unvieristy of North Carolina - Chapel Hill
Chapel Hill, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Richard H. Weisler, Md, Pa and Associates
Raleigh, North Carolina, United States
- University of Cincinnati
Cincinnati, Ohio, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Midwest Clinical Research Center
Dayton, Ohio, United States
- Ips Research Company
Oklahoma City, Oklahoma, United States
- Oregon Center for Clinical Investigations, Inc.
Portland, Oregon, United States
- Western Psychiatric Institute Clinic
Pittsburgh, Pennsylvania, United States
- Lincoln Research
Lincoln, Rhode Island, United States
- Ralph H. Johnson Va Medical Center
Charleston, South Carolina, United States
- Cns Healthcare
Memphis, Tennessee, United States
- Vanderbilt University School of Medicine
Nashville, Tennessee, United States
- Futuresearch Trials of Austin
Austin, Texas, United States
- Futuresearch Trials of Dallas
Dallas, Texas, United States
- University of Texas, Houston Medical Center
Houston, Texas, United States
- University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States
- University of Utah
Salt Lake City, Utah, United States
- University of Virginia
Charlottesville, Virginia, United States
- Northwest Clinical Research Center
Bellevue, Washington, United States
- Dean Foundation
Middleton, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2008
- Primary completion
- 31 Dec 2010
- Completion
- 31 Dec 2010
- Last update posted
- 17 Jan 2011
- Registered enrollment
- 180
- Registry id
- NCT00812058
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.